IBDEI1OE ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28038,1,4,0)
 ;;=4^K74.69
 ;;^UTILITY(U,$J,358.3,28038,2)
 ;;=^5008823
 ;;^UTILITY(U,$J,358.3,28039,0)
 ;;=K74.60^^132^1323^11
 ;;^UTILITY(U,$J,358.3,28039,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28039,1,3,0)
 ;;=3^Cirrhosis of Liver,Unspec
 ;;^UTILITY(U,$J,358.3,28039,1,4,0)
 ;;=4^K74.60
 ;;^UTILITY(U,$J,358.3,28039,2)
 ;;=^5008822
 ;;^UTILITY(U,$J,358.3,28040,0)
 ;;=K76.0^^132^1323^12
 ;;^UTILITY(U,$J,358.3,28040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28040,1,3,0)
 ;;=3^Fatty Liver NEC
 ;;^UTILITY(U,$J,358.3,28040,1,4,0)
 ;;=4^K76.0
 ;;^UTILITY(U,$J,358.3,28040,2)
 ;;=^5008831
 ;;^UTILITY(U,$J,358.3,28041,0)
 ;;=K76.89^^132^1323^18
 ;;^UTILITY(U,$J,358.3,28041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28041,1,3,0)
 ;;=3^Liver Disease NEC
 ;;^UTILITY(U,$J,358.3,28041,1,4,0)
 ;;=4^K76.89
 ;;^UTILITY(U,$J,358.3,28041,2)
 ;;=^5008835
 ;;^UTILITY(U,$J,358.3,28042,0)
 ;;=K71.6^^132^1323^32
 ;;^UTILITY(U,$J,358.3,28042,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28042,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatitis NEC
 ;;^UTILITY(U,$J,358.3,28042,1,4,0)
 ;;=4^K71.6
 ;;^UTILITY(U,$J,358.3,28042,2)
 ;;=^5008801
 ;;^UTILITY(U,$J,358.3,28043,0)
 ;;=K75.9^^132^1323^17
 ;;^UTILITY(U,$J,358.3,28043,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28043,1,3,0)
 ;;=3^Inflammatory Liver Disease,Unspec
 ;;^UTILITY(U,$J,358.3,28043,1,4,0)
 ;;=4^K75.9
 ;;^UTILITY(U,$J,358.3,28043,2)
 ;;=^5008830
 ;;^UTILITY(U,$J,358.3,28044,0)
 ;;=K71.0^^132^1323^24
 ;;^UTILITY(U,$J,358.3,28044,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28044,1,3,0)
 ;;=3^Toxic Liver Disease w/ Cholestasis
 ;;^UTILITY(U,$J,358.3,28044,1,4,0)
 ;;=4^K71.0
 ;;^UTILITY(U,$J,358.3,28044,2)
 ;;=^5008793
 ;;^UTILITY(U,$J,358.3,28045,0)
 ;;=K71.10^^132^1323^30
 ;;^UTILITY(U,$J,358.3,28045,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28045,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/o Coma
 ;;^UTILITY(U,$J,358.3,28045,1,4,0)
 ;;=4^K71.10
 ;;^UTILITY(U,$J,358.3,28045,2)
 ;;=^5008794
 ;;^UTILITY(U,$J,358.3,28046,0)
 ;;=K71.11^^132^1323^31
 ;;^UTILITY(U,$J,358.3,28046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28046,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/ Coma
 ;;^UTILITY(U,$J,358.3,28046,1,4,0)
 ;;=4^K71.11
 ;;^UTILITY(U,$J,358.3,28046,2)
 ;;=^5008795
 ;;^UTILITY(U,$J,358.3,28047,0)
 ;;=K71.2^^132^1323^23
 ;;^UTILITY(U,$J,358.3,28047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28047,1,3,0)
 ;;=3^Toxic Liver Disease w/ Acute Hepatitis
 ;;^UTILITY(U,$J,358.3,28047,1,4,0)
 ;;=4^K71.2
 ;;^UTILITY(U,$J,358.3,28047,2)
 ;;=^5008796
 ;;^UTILITY(U,$J,358.3,28048,0)
 ;;=K71.3^^132^1323^28
 ;;^UTILITY(U,$J,358.3,28048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28048,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Persistent Hepatitis
 ;;^UTILITY(U,$J,358.3,28048,1,4,0)
 ;;=4^K71.3
 ;;^UTILITY(U,$J,358.3,28048,2)
 ;;=^5008797
 ;;^UTILITY(U,$J,358.3,28049,0)
 ;;=K71.4^^132^1323^27
 ;;^UTILITY(U,$J,358.3,28049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28049,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Lobular Hepatitis
 ;;^UTILITY(U,$J,358.3,28049,1,4,0)
 ;;=4^K71.4
 ;;^UTILITY(U,$J,358.3,28049,2)
 ;;=^5008798
 ;;^UTILITY(U,$J,358.3,28050,0)
 ;;=K75.81^^132^1323^19
 ;;^UTILITY(U,$J,358.3,28050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28050,1,3,0)
 ;;=3^Nonalcoholic Steatohepatitis (NASH)
 ;;^UTILITY(U,$J,358.3,28050,1,4,0)
 ;;=4^K75.81
 ;;^UTILITY(U,$J,358.3,28050,2)
 ;;=^5008828
 ;;^UTILITY(U,$J,358.3,28051,0)
 ;;=K75.89^^132^1323^16
 ;;^UTILITY(U,$J,358.3,28051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28051,1,3,0)
 ;;=3^Inflammatory Liver Disease,Oth Spec
